Multiple Sclerosis Study – Now Enrolling
The FLUENT MS study is for patients who have relapsing MS and who will begin fingolimod therapy OR have been taking fingolimod therapy for at least 2 years. The purpose of this study will help determine how fingolimod affects the immune system by measuring substances in the blood called biomarkers. Participation lasts about a year and requires 4 blood samples to be taken: at your first study visit, after you qualify, and at approximately 3,6, and 12 months.
If you, your family member or loved one is interested in learning more about participating in this study, please contact the Study Coordinator at 520-320-2157.